Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Non-Current Debt (2023 - 2026)

OptimizeRx's Non-Current Debt history spans 3 years, with the latest figure at $21.4 million for Q4 2025.

  • On a quarterly basis, Non-Current Debt fell 30.49% to $21.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $21.4 million, a 30.49% decrease, with the full-year FY2025 number at $21.4 million, down 30.49% from a year prior.
  • Non-Current Debt hit $21.4 million in Q4 2025 for OptimizeRx, down from $24.8 million in the prior quarter.
  • Over the last five years, Non-Current Debt for OPRX hit a ceiling of $34.2 million in Q4 2023 and a floor of $21.4 million in Q4 2025.
  • Historically, Non-Current Debt has averaged $29.3 million across 3 years, with a median of $30.8 million in 2024.
  • The widest YoY moves for Non-Current Debt: up 9.94% in 2025, down 30.49% in 2025.
  • Tracing OPRX's Non-Current Debt over 3 years: stood at $34.2 million in 2023, then dropped by 9.98% to $30.8 million in 2024, then crashed by 30.49% to $21.4 million in 2025.
  • Business Quant data shows Non-Current Debt for OPRX at $21.4 million in Q4 2025, $24.8 million in Q3 2025, and $25.1 million in Q2 2025.